We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+3.75%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$948M
AUM Growth
+$41M
Cap. Flow
+$12.7M
Cap. Flow %
1.34%
Top 10 Hldgs %
27.51%
Holding
266
New
20
Increased
64
Reduced
83
Closed
5

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$8.88M
2
WAB icon
Wabtec
WAB
+$4.45M
3
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$2.26M
4
JPM icon
JPMorgan Chase
JPM
+$1.62M
5
XLRN
Acceleron Pharma
XLRN
+$1.57M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$6.45M
2
WFC icon
Wells Fargo
WFC
+$1.74M
3
HSIC icon
Henry Schein
HSIC
+$1.42M
4
UPS icon
United Parcel Service
UPS
+$1.09M
5
CB icon
Chubb
CB
+$910K

Sector Composition

Rank Sector Weight
1 Healthcare 16.99%
2 Industrials 14.77%
3 Financials 14.58%
4 Technology 13.43%
5 Energy 11.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ETN icon
151
Eaton
ETN
$174B
$558K 0.06%
7,475
-1,000
-12% -$77.3K
AEP icon
152
American Electric Power
AEP
$68.7B
$551K 0.06%
7,959
+1,571
+25% +$106K
MPC icon
153
Marathon Petroleum
MPC
$83.3B
$549K 0.06%
7,832
– –
CMCSA icon
154
Comcast
CMCSA
$90.2B
$512K 0.05%
15,612
-652
-4% -$21.2K
A icon
155
Agilent Technologies
A
$41.1B
$503K 0.05%
8,128
– –
PAA icon
156
Plains All American Pipeline
PAA
$16.1B
$501K 0.05%
21,213
-700
-3% -$16.9K
ADM icon
157
Archer Daniels Midland
ADM
$36.8B
$481K 0.05%
10,500
-500
-5% -$22.5K
CERN
158
DELISTED
Cerner Corp
CERN
$478K 0.05%
8,000
– –
MDLZ icon
159
Mondelez International
MDLZ
$80.1B
$469K 0.05%
11,430
– –
SNA icon
160
Snap-on
SNA
$21.5B
$458K 0.05%
2,850
– –
ROP icon
161
Roper Technologies
ROP
$39.7B
$436K 0.05%
1,580
-210
-12% -$57.9K
OUT icon
162
Outfront Media
OUT
$5.45B
$428K 0.05%
22,351
– –
DTE icon
163
DTE Energy
DTE
$29.2B
$420K 0.04%
4,759
– –
DOV icon
164
Dover
DOV
$28.5B
$419K 0.04%
5,732
-1,785
-24% -$137K
HPE icon
165
Hewlett Packard
HPE
$69.9B
$415K 0.04%
28,421
– –
WHWK
166
Whitehawk Therapeutics
WHWK
$234M
$415K 0.04%
+6,667
New +$403K
VWO icon
167
Vanguard FTSE Emerging Markets ETF
VWO
$124B
$400K 0.04%
9,475
– –
ECL icon
168
Ecolab
ECL
$79.7B
$396K 0.04%
2,825
+250
+10% +$36.1K
ETP
169
DELISTED
Energy Transfer Partners, L.P.
ETP
$390K 0.04%
20,451
– –
UTG icon
170
Reaves Utility Income Fund
UTG
$3.61B
$388K 0.04%
13,418
– –
STT icon
171
State Street
STT
$50.8B
$386K 0.04%
4,150
– –
BBT.PRD.CL
172
DELISTED
BB&T CORPORATION Depositary Shares, representing 1/1,000th interest in a share of Series D Non-Cumul
BBT.PRD.CL
$380K 0.04%
14,800
-1,000
-6% -$25.5K
PXD
173
DELISTED
Pioneer Natural Resource Co.
PXD
$377K 0.04%
1,990
– –
ADI icon
174
Analog Devices
ADI
$190B
$373K 0.04%
+3,889
New +$367K
BDX icon
175
Becton Dickinson
BDX
$48.6B
$370K 0.04%
1,583
+62
+4% +$13.8K
5 6
7
8 9

Similar funds

BGCP
Bristol Gate Capital Partners Toronto, Ontario, Canada $1.55B AUM 12.75% 1-Year Est. Return
MSA
MUFG Securities Americas New York $1.55B AUM 28.4% 1-Year Est. Return
CET
Clean Energy Transition London, United Kingdom $1.54B AUM 34.41% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
CCM
Cinctive Capital Management New York $1.53B AUM 48.83% 1-Year Est. Return
TNBTD
Trustmark National Bank Trust Department Jackson, Mississippi $1.56B AUM 16.53% 1-Year Est. Return
MCP
Meridiem Capital Partners Dallas, Texas $1.53B AUM 17.03% 1-Year Est. Return
SG
Sienna Gestion Paris, France $1.53B AUM 27.73% 1-Year Est. Return

Neville Rodie & Shaw's Q2 2018 Portfolio in Review

As of Q2 2018, Neville Rodie & Shaw held 266 positions worth $948M, up 4.5% from $907M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Neville Rodie & Shaw's Q2 2018 filing shows 20 new, 64 increased, 83 reduced and 5 closed positions. Its largest new stake was Acceleron Pharma: 42,964 shares worth $2.08M. The largest sale was Invesco QQQ Trust, an estimated $6.45M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Industrials and Financials.

  • Neville Rodie & Shaw's largest Q2 2018 buy was Acceleron Pharma: 42,964 shares worth $2.08M.
  • Neville Rodie & Shaw added most to Allergan plc in Q2 2018, an estimated $8.88M increase.
  • Neville Rodie & Shaw's biggest Q2 2018 reduction was Wells Fargo, cutting an estimated $1.74M.
  • Neville Rodie & Shaw fully exited Invesco QQQ Trust in Q2 2018, selling an estimated $6.45M.
  • Neville Rodie & Shaw's ten largest holdings make up 28% of its $948M portfolio in Q2 2018.
  • Neville Rodie & Shaw opened 20 new positions and closed 5 in Q2 2018.
  • Neville Rodie & Shaw's portfolio value rose 4.5% quarter-over-quarter to $948M.

Based on Neville Rodie & Shaw's 13F filing for Q2 2018, filed 3 Jul 2018.